Literature DB >> 9095175

Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein.

L Benimetskaya1, J D Loike, Z Khaled, G Loike, S C Silverstein, L Cao, J el Khoury, T Q Cai, C A Stein.   

Abstract

We have studied the interactions of phosphodiester and phosphorothioate oligodeoxynucleotides with Mac-1 (CD11b/CD18; alpha M beta 2), a heparin-binding integrin found predominantly on the surface of polymorphonuclear leukocytes (PMNs), macrophages and natural killer cells. Binding of a homopolymer of thymidine occurred on both the alpha M and beta 2 subunits. Soluble fibrinogen, a natural ligand for Mac-1, was an excellent competitor of the binding of a phosphorothioate oligodeoxynucleotide to both TNF-alpha-activated and nonactivated PMNs. Upregulation of cell-surface Mac-1 expression increased cell-surface binding of oligodeoxynucleotides. Binding was inhibited by anti-Mac-1 monoclonal antibodies, and the increase in cell-surface binding was correlated with a three- to fourfold increase in internalization by PMNs. An oligodeoxynucleotide inhibited beta 2-dependent migration through Matrigel, but the production of reactive oxygen species in PMNs adherent to fibrinogen dramatically increased. Thus, our data demonstrate that Mac-1 is a cell-surface receptor for oligodeoxynucleotides that can mediate their internalization and that this binding may have important functional consequences.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9095175     DOI: 10.1038/nm0497-414

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  50 in total

1.  Dynamics of phosphorothioate oligonucleotides in normal and laser photocoagulated retina.

Authors:  W Y Shen; K L Garrett; L da Cruz; I J Constable; P E Rakoczy
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 2.  The influence of base sequence on the immunostimulatory properties of DNA.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  Activation of NK cell (human and mouse) by immunostimulatory DNA sequence.

Authors:  S Yamamoto; T Yamamoto; S Iho; T Tokunaga
Journal:  Springer Semin Immunopathol       Date:  2000

4.  Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.

Authors:  Philippe de Diesbach; Francisca N'Kuli; Catherine Berens; Etienne Sonveaux; Michel Monsigny; Annie-Claude Roche; Pierre J Courtoy
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

5.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 6.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

7.  Metabolic biotinylation of recombinant proteins in mammalian cells and in mice.

Authors:  M B Parrott; M A Barry
Journal:  Mol Ther       Date:  2000-01       Impact factor: 11.454

8.  Characterization of plasmid DNA binding and uptake by peritoneal macrophages from class A scavenger receptor knockout mice.

Authors:  Y Takakura; T Takagi; M Hashiguchi; M Nishikawa; F Yamashita; T Doi; T Imanishi; H Suzuki; T Kodama; M Hashida
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

Review 9.  Traditional biochemical assays for studying toll-like receptor 9.

Authors:  Cynthia A Leifer; William A Rose; Fernando Botelho
Journal:  J Immunoassay Immunochem       Date:  2013

10.  Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-κB decoy oligodeoxynucleotide: a preliminary report.

Authors:  Tzu-Hua Lin; Zhenyu Yao; Taishi Sato; Michael Keeney; Chenguang Li; Jukka Pajarinen; Fan Yang; Kensuke Egashira; Stuart B Goodman
Journal:  Acta Biomater       Date:  2014-05-09       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.